Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19
August 19, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis. and MORGAN HILL, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit,...
Monopar宣布计划利用其专利技术推进重症新冠肺炎新型分流检测的开发
August 12, 2020 08:45 ET
|
Monopar Therapeutics Inc.
伊利诺伊州威尔梅特, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（Nasdaq: MNPR）今天宣布了一种检测方法的开发计划，这种方法有可能按发展为重度呼吸系统衰竭的可能性来对新冠肺炎患者进行分流。这项检测将使用Monopar拥有专利的单克隆抗体ATN-658来探测新冠肺炎患者血浆中的可溶性尿激酶型纤溶酶原激活物受体...
Monopar Announces Plan to Advance Development of Novel Triage Test for Severe COVID-19 Utilizing its Patented Technology
August 12, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced its plan to develop a test to potentially triage COVID-19 patients into those likely versus...
Monopar和NorthStar与IsoTherapeutics就重症新冠肺炎潜在疗法的生产达成合作关系
August 10, 2020 08:30 ET
|
Monopar Therapeutics Inc.
伊利诺伊州威尔梅特、威斯康星州贝洛伊特和德克萨斯州安格尔顿, Aug. 10, 2020 (GLOBE NEWSWIRE) -- 正在合作开发用以治疗新冠肺炎重症患者的放射免疫疗法（RIT）的Monopar Therapeutics Inc. (Nasdaq: MNPR)（伊利诺伊州威尔梅特）和NorthStar Medical Radioisotopes,...
Monopar and NorthStar Partner with IsoTherapeutics for the Manufacturing of Potential Therapeutic for Severe COVID-19
August 10, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis. and ANGLETON, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI),...
Monopar Therapeutics Reports Second Quarter 2020 Financial Results and Business Updates
August 06, 2020 16:05 ET
|
Monopar Therapeutics Inc.
CHICAGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary...
Monodar和NorthStar宣布提交临时专利申请，保护通过uPAR的重症新冠肺炎放射免疫疗法 (RIT) 的开发和应用
June 30, 2020 11:17 ET
|
Monopar Therapeutics Inc.
芝加哥和威斯康辛州贝洛伊特, June 30, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR)（伊利诺斯芝加哥）和NorthStar Medical Radioisotopes,...
Monopar and NorthStar Announce Filing of Provisional Patent Protecting Development and Use of Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19 Through uPAR
June 30, 2020 08:25 ET
|
Monopar Therapeutics Inc.
CHICAGO and BELOIT, Wis., June 30, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today that a...
Monodar和NorthStar联合开发针对重症新冠肺炎的放射性同位素免疫疗法（RIT）
June 17, 2020 09:29 ET
|
Monopar Therapeutics Inc.
芝加哥和威斯康星州伯洛伊特, June 17, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（纳斯达克：MMPR）（伊利诺伊州芝加哥）和NorthStar Medical Radioisotopes,...
Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19
June 16, 2020 08:25 ET
|
Monopar Therapeutics Inc.
CHICAGO and BELOIT, Wis., June 16, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today a 50/50...